Kaken Pharmaceutical Co., Ltd. (TYO:4521)
Japan · Delayed Price · Currency is JPY 3,795.00
-25.00 (-0.65%)
Aug 4, 2026, 10:04 AM JST
Kaken Pharmaceutical Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Kaken Pharmaceutical stock has a consensus rating of "Hold" and an average price target of ¥4,500. The average 1-year stock price forecast is 18.58% higher than the current stock price, while the lowest is ¥4,000 (+5.40%) and the highest is ¥5,300 (+39.66%).
Price Target: ¥4,500 (+18.58%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Kaken Pharmaceutical stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
82.82B
from 76.87B
Increased by 7.74%
Revenue Next Year
81.69B
from 82.82B
Decreased by -1.37%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.